Histamine receptor
US6613533B2 · kind B2 · utility
2Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2001 |
| Grant date | Sep 2, 2003 |
| Priority date | — |
| Expiry date | Apr 26, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4719
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides an isolated mammalian histamine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by histamine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.